Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Schlichtig K"'
Autor:
Cuba L; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Dürr P; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Dörje F; Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.; FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jul; Vol. 116 (1), pp. 194-203. Date of Electronic Publication: 2024 Apr 24.
Autor:
Cuba L; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Dürr P; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Inwald EC; Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Dörje F; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.
Publikováno v:
Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2023 Jun 03; Vol. 11 (11). Date of Electronic Publication: 2023 Jun 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Erlangen, Germany., Dürr P; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany., Dörje F; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, Erlangen, Germany.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Oct; Vol. 110 (4), pp. 1075-1086. Date of Electronic Publication: 2021 Jul 18.
Autor:
Dürr P; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Meier F; Department of Management and Economics, SRH Wilhelm Löhe University of Applied Sciences, 90763 Fürth, Germany., Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Schramm A; AOK Bayern, 93055 Regensburg, Germany., Schötz L; AOK Bayern, 93055 Regensburg, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Dörje F; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Oct 28; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 28.
Autor:
Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Cuba L; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany., Dürr P; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany., Bellut L; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany., Meidenbauer N; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, Erlangen University Hospital, 91054 Erlangen, Germany., Kunath F; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany., Goebell PJ; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany., Mackensen A; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, Erlangen University Hospital, 91054 Erlangen, Germany., Dörje F; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Pharmacy Department, Erlangen University Hospital, 91054 Erlangen, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany., Wullich B; Comprehensive Cancer Center Erlangen-EMN, Erlangen University Hospital, 91054 Erlangen, Germany.; Department of Urology and Pediatric Urology, Erlangen University Hospital, 91054 Erlangen, Germany.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2022 Aug 04; Vol. 11 (15). Date of Electronic Publication: 2022 Aug 04.
Autor:
Dürr P; Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie, Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland; Apotheke des Universitätsklinikums Erlangen, Erlangen, Deutschland; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Deutschland., Schlichtig K; Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie, Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Deutschland., Krebs S; Apotheke des Universitätsklinikums Erlangen, Erlangen, Deutschland; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Deutschland., Schramm A; AOK Bayern, Regensburg, Deutschland., Schötz L; AOK Bayern, Regensburg, Deutschland., Fromm MF; Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie, Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Deutschland., Dörje F; Apotheke des Universitätsklinikums Erlangen, Erlangen, Deutschland; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Deutschland. Electronic address: frank.doerje@uk-erlangen.de.
Publikováno v:
Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen [Z Evid Fortbild Qual Gesundhwes] 2022 Apr; Vol. 169, pp. 84-93. Date of Electronic Publication: 2022 Mar 03.
Autor:
Kehl N; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany., Schlichtig K; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany., Dürr P; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Pharmacy Department, University Hospital Erlangen, 91054 Erlangen, Germany., Bellut L; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Department of Urology, University Hospital Erlangen, 91054 Erlangen, Germany., Dörje F; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Pharmacy Department, University Hospital Erlangen, 91054 Erlangen, Germany., Fietkau R; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Department of Radiation Oncology, University Hospital Erlangen, 91054 Erlangen, Germany., Pavel M; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Department of Internal Medicine 1, University Hospital Erlangen, 91054 Erlangen, Germany., Mackensen A; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, 91054 Erlangen, Germany., Wullich B; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.; Department of Urology, University Hospital Erlangen, 91054 Erlangen, Germany., Maas R; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany., Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany., Gessner A; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany., Taudte RV; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), University Hospital Erlangen, 91054 Erlangen, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 16; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 16.
Autor:
Dürr P; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany., Schlichtig K; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Kelz C; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Deutsch B; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Maas R; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Eckart MJ; Practice for Hematology and Oncology, Erlangen, Germany., Wilke J; Practice for Hematology and Oncology, Fürth, Germany., Wagner H; Practice for Hematology and Oncology, Fürth, Germany., Wolff K; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 1, University Hospital Erlangen, Erlangen, Germany., Preuß C; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Obstetrics and Gynecology, University Hospital Erlangen, Erlangen, Germany., Brückl V; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Meidenbauer N; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Staerk C; Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany., Mayr A; Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany., Fietkau R; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany., Goebell PJ; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Erlangen, Germany., Kunath F; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Urology and Pediatric Urology, University Hospital Erlangen, Erlangen, Germany., Beckmann MW; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Obstetrics and Gynecology, University Hospital Erlangen, Erlangen, Germany., Mackensen A; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Neurath MF; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 1, University Hospital Erlangen, Erlangen, Germany., Pavel M; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Department of Internal Medicine 1, University Hospital Erlangen, Erlangen, Germany., Dörje F; Pharmacy Department, Erlangen University Hospital, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany., Fromm MF; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany.; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jun 20; Vol. 39 (18), pp. 1983-1994. Date of Electronic Publication: 2021 Apr 06.
Autor:
Lensker, Phyllis1,2,3,4 (AUTHOR), Cuba, Lisa1,2,3 (AUTHOR), Gessner, Katja2,3 (AUTHOR), Fromm, Martin F.2,3,5 (AUTHOR), Dörje, Frank1,3,5 (AUTHOR), Metzler, Markus3,4 (AUTHOR) markus.metzler@uk-erlangen.de
Publikováno v:
PLoS ONE. 12/5/2024, Vol. 19 Issue 12, p1-15. 15p.